Researchers studied how a heart medication called Entresto affects rats that were fed a high-protein diet and had both heart and kidney problems. The study found that Entresto helped protect heart cells and kept the heart working better by reducing harmful stress inside cells and fixing tiny energy factories called mitochondria. This research suggests the medication might help people with similar heart and kidney issues, though more human studies are needed to confirm these findings.
The Quick Take
- What they studied: Whether a heart medication called Entresto could protect heart cells and improve heart function in animals with both heart and kidney disease caused by eating too much protein
- Who participated: Laboratory rats that were given a high-protein diet to create heart and kidney problems similar to what some humans experience
- Key finding: Entresto appeared to protect heart cells and maintain better heart function by reducing cellular damage and restoring the function of mitochondria, which are the energy-producing parts of cells
- What it means for you: This research suggests Entresto might be helpful for people with combined heart and kidney problems, but this was animal research only. Human studies would be needed before doctors could recommend this approach based on these findings.
The Research Details
This was a laboratory study using rats to test how Entresto affects heart and kidney disease. The researchers created disease in rats by feeding them a high-protein diet, which caused both heart and kidney problems similar to a condition called cardiorenal syndrome that affects some humans. They then gave some rats Entresto and compared their heart health to rats that didn’t receive the medication. The researchers measured several things including how well the heart worked, how much cellular damage occurred, and whether the tiny energy factories inside cells (mitochondria) were functioning properly.
Animal studies like this help scientists understand how medications work at the cellular level before testing them in humans. By studying rats with similar disease patterns to humans, researchers can learn whether a medication is worth testing in people and understand the biological mechanisms that make it work.
This is a corrigendum, which means it’s a correction to a previously published study. The original research was published in a peer-reviewed scientific journal, which means other experts reviewed it. However, because this is animal research, results may not directly apply to humans. The study appears to have measured multiple important outcomes related to heart and kidney function.
What the Results Show
The main finding was that rats receiving Entresto showed better heart function compared to rats that didn’t receive the medication. The hearts of treated rats appeared to maintain better pumping ability and showed less damage. Additionally, Entresto appeared to reduce oxidative stress, which is a type of cellular damage caused by harmful molecules called free radicals. The medication also seemed to help restore the function of mitochondria, the energy-producing structures inside cells that are crucial for heart health.
The study also found that Entresto helped protect heart cells from dying and reduced inflammation in heart tissue. These secondary findings support the main conclusion that the medication provides multiple protective effects on the heart.
This research builds on previous studies showing that Entresto can help heart function in various conditions. The novel aspect of this study is examining how it works specifically in the combination of heart and kidney disease with high protein intake, which is a less-studied scenario.
This study was conducted only in laboratory rats, not in humans. Results in animals don’t always translate to humans due to differences in biology and metabolism. The study doesn’t tell us what dose would be appropriate for humans or whether the same protective effects would occur. Additionally, we don’t know if these benefits would last long-term in real patients or how they might interact with other medications people take.
The Bottom Line
Based on this animal research, Entresto shows potential for protecting heart function in people with combined heart and kidney disease. However, this is preliminary evidence. Anyone with heart or kidney disease should continue following their doctor’s current treatment plan. This research suggests Entresto might be worth further study in human patients, but it’s not yet a proven treatment based on this evidence alone. Confidence level: Low to Moderate (animal study only).
People with cardiorenal syndrome (combined heart and kidney disease) and their doctors should be aware of this research as it suggests a potential treatment avenue. Researchers studying heart and kidney disease should also pay attention. People without these conditions don’t need to change anything based on this study.
This is animal research, so there’s no realistic timeline for human benefits yet. If human studies are conducted, it would typically take several years to determine whether Entresto provides similar benefits in people and whether it’s safe for long-term use.
Want to Apply This Research?
- If prescribed Entresto by a doctor, users could track heart-related symptoms weekly: shortness of breath during normal activities, ankle swelling, fatigue levels, and exercise tolerance on a scale of 1-10
- Users could combine Entresto tracking with monitoring protein intake and daily activity levels, since the study involved high-protein diet effects. This creates a complete picture of heart and kidney health management
- Set monthly reminders to check in on overall energy levels, exercise capacity, and any swelling or breathing changes. Share trends with healthcare provider during regular checkups to assess whether the medication is working as expected
This research was conducted in laboratory rats and has not been tested in humans. The findings are preliminary and should not be used to make treatment decisions. Anyone with heart or kidney disease should consult with their healthcare provider before making any changes to their treatment plan. This summary is for educational purposes only and is not medical advice. Always follow your doctor’s recommendations for managing heart and kidney conditions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.